• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Biognosys AG

Biognosys is a leader in next-generation proteomics, dedicated to transforming life science research by developing the most advanced proteomics tools and making them available for pharmaceutical and biotech research and development. The company offers a suite of products and services to decode the proteome and equip researchers from all fields with a deep view of protein expression and regulation in cells, tissues, or body fluids. Biognosys’ technology is based on high-resolution mass spectrometry, combined with a novel parallel signal processing approach, for unprecedented quantification of large proteomes in a single experiment. *

 

	Start	2008-09-09 splitoff
	Predecessor	ETH Zürich (ETHZ)
	Industry	proteomics
	Industry 2	multiple reaction monitoring (MRM) technology
	Person	Rinner, Oliver (Biognosys 201212– CSO + founder before CEO)
	Person 2	Novak, Lidia (Biognosys 2019089 CFO)
	Region	Schlieren ZH
	Country	Switzerland
	Street	25 Wagistr. Bio-Technopark
	City	8952 Schlieren ZH
	Tel	+41-44-738-2040
		Address record changed: 2021-04-13
Basic data	Employees	n. a.
		* Document for �About Section�: Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren.
		Record changed: 2021-05-20

Advertisement

More documents for Biognosys AG

• [1] Biognosys AG. (5/19/21). "Press Release: Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer". Schlieren....
• [2] Biognosys AG. (4/13/21). "Press Release: Biognosys Announces Strategic Agreement with Siemens Healthineers"....
• [3] Biognosys AG. (1/21/21). "Press Release: Biognosys Announces Appointment of Karel Novy as Chief Operating Officer"....
• [4] Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren....
• [5] Biognosys AG. (4/28/20). "Press Release: Gustave Roussy and Biognosys Announce Partnership". Schlieren & Villejuif....
• [6] Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren....
• [7] Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide....
• [8] Biognosys AG. (8/8/19). "Press Release: Biognosys Completes Series G Financing Round to Accelerate its Expansion into Clinical Trials Market". Schlieren....
• [9] Biognosys AG. (5/30/18). "Press Release: Introducing PQ500"....
• [10] Freenome, Inc.. (4/24/18). "Press Release: Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatment". South San Francisco, CA & Zurich....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.